We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Face2Gene Screenshots

About Face2Gene

Face2Gene — Smart Phenotyping. Better Genetics.

FACE2GENE IS DESIGNATED TO BE USED SOLELY BY HEALTHCARE PROFESSIONALS AND SHOULD NOT BE USED WITHOUT PROPER MEDICAL TRAINING.

A deep phenotyping app that facilitates comprehensive and precise genetic evaluations and to assess the likelihood that a patient may benefit from further testing to uncover possible underlying genetic conditions.

The Face2Gene app includes the following features:

Clinic – Enhanced Patient Evaluation with Deep Phenotyping

* Detect Dysmorphic Features & Reveal Related Traits

* Discover Relevant Genetic Disorders

* Includes London Medical Database (LMD)

* Access the Pediatrician View

Forums - Collaborative Case Review for Diagnostic Dilemmas

* Share cases in secure group forums

* Comment on other cases and receive feedback on your cases

* Community created solely for health care professionals

Compliant with HIPAA and GDPR security and privacy.

Face2Gene is a search & reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.

What's New in the Latest Version 5.2.20

Last updated on Jan 11, 2025

Fixes in user settings

Translation Loading...

Additional APP Information

Latest Version

Request Face2Gene Update 5.2.20

Uploaded by

Cyno Dam

Requires Android

Android 7.0+

Available on

Get Face2Gene on Google Play

Show More
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.